andrew huberman retatrutide Neuroscientist discusses retatrutide, a treatment that could help people lose up to a third of their body weight with minimal muscle loss. >> 👇More below👇 Medium

doi:10.2337/db11-0132 51

Misuse and diversion of stimulant medications prescribed for the treatment of ADHD: a systematic review

- Mantenha seus manipulados em locais secos, arejados e protegidos da luz

Dosing patterns for hormonal phases While the standard prescribing information for GLP-1 medications like semaglutide or tirzepatide does not include official information for customized dosing based on a patients hormonal phases, there is emerging clinical practice and research focusing on personalized dosing strategies, particularly for women experiencing hormonal shifts

Although this supposed correlation has a great impact on the mass media, most clinical and epidemiological reports to date have not revealed a causal relationship between growth hormone therapy and as a consequence of an increase in IGF-1 levels and an increased risk of cancer (Werner & Laron., 2020)